BTC Health Ltd Registered · ASX:BTC
BTC Health Ltd Registered — BTC Health — Investor Presentation (December 2019)
21 slides from BTC Health Ltd Registered's investor presentation, Dec 3, 2019
Slide 1: Investor Presentation
For personal use only Investor Presentation 3-4 December 2019 Richard Treagus Executive Chairman
Slide 2: Forward Looking Statements
Forward Looking Statements For personal use only This presentation contains forward looking statements that involve risks and uncertainties. Although we believe that the expectations and assumptions reflected in the forward looking statements are reasonable at this time, BTC health can give no assur
Slide 3: About BTC health
About BTC health For personal use only BTC health is focused on the development and commercialization of specialized medical products distributed though hospitals. The company’s objective is to be a leading supplier of novel, high-quality products, building revenues and profitability over time throu
Slide 4: Board of Directors
Board of Directors For personal use only Richard Treagus – Executive Chairman BScMed, MBChB, MPharmMed, MBA, MAICD. Richard is a physician and entrepreneur with more than 20 years’ experience across the international pharmaceutical and biotechnology industry. Richard is Executive Chairman of Neuren
Slide 5: Highly capable and experienced executive team
Highly capable and experienced executive team For personal use only Richard Treagus – Executive Chairman • More than 25 years experience in the international pharmaceutical and healthcare industry • Formerly head of sales, marketing and business development at Aspen Pharmacare and Sigma • An extensi
Slide 6: Pooled Development Fund Overview
Pooled Development Fund Overview A beneficial structure for shareholders For personal use only BTC health is registered as a Pooled Development Fund A (PDF), giving the company and its shareholders access to substantial tax concessions and benefits.* B Shareholders are entitled to concessionary tax
Slide 7: Vision and Growth Strategy
Vision and Growth Strategy BTC health’s vision is to be a leading supplier of specialized medical products in Australia and NZ For personal use only Shareholder value * 3. Value accretive acquisitions 2. Partnering & Product development: diversity & scale 1. Hospital infusion acquisition: platform f
Slide 8: Australian Hospital Market
1. Hospital infusion acquisition: platform for growth Australian Hospital Market For personal use only PUBLIC HOSPITALS* • 695 Public Hospitals with 62,000 beds Hospital expenditure • $67 billion recurring expenditure in public hospitals continues to grow (increased by 3.2% after inflation adjustmen
Slide 9: Customer base & sales profile
1. Hospital infusion acquisition: platform for growth Customer base & sales profile Existing customer base Historic sales and forecast For personal use only • Sales of infusion products into 126 hospitals. • Opportunity to increase sales within existing customer base and beyond. • Capacity to introd
Slide 10: Business infrastructure
1. Hospital infusion acquisition: platform for growth Business infrastructure For personal use only • >95% of current sales within Australia • Existing hospital customers in all major cities and regional centers • Experienced national sales and specialist education team • CHS (Sigma) provide wholesa
Slide 11: Hospital infusion acquisition
1. Hospital infusion acquisition: platform for grow For personal use only BTC heath Limited (“BTC”) funded the Hospital infusion acquisition via private placement Hospital Infusion Business acquired Transfer and employment of key from Admedus Limited, (excluding nominated staff comprising a national
Slide 12: ambIT infusion pumps
1. Hospital infusion acquisition: platform for growth ambIT® infusion pumps For personal use only Innovative ambulatory infusion pumps provide patients, doctors and hospitals a portable, flexible and cost-effective alternative to traditional stationary pumps. The ambIT® pumps are; • designed to allo
Slide 13: Other Products
1. Hospital infusion acquisition: platform for growth Other Products For personal use only ELDOR Wound Catheter Specialised fenestrated catheters for infusion of local anesthetic into surgical sites for post-operative pain management. CSEN Ultrasound guided needles Rainbow Tray™ An innovative, simpl
Slide 14: Partnering & Product development: Significant opportunities in the pipeline
2. Partnering & Product development: diversity & scale Significant opportunities in the pipeline For personal use only Exclusive supply agreements Targeting 1-2 new product for Australia and New Zealand introductions per year Typical incremental revenues Strong synergies with of $1-3M p.a. for each
Slide 15: New Product Pipeline
2. Partnering & Product development: diversity & scale New Product Pipeline CAMURUS AB (Sweden) For personal use only - Addressable market 20,000 cancer patients p.a. (Grade 3 & 4 Oral mucositis) - Estimated sales potential approximately $750k p.a. • Exclusive license agreement for Episil® oral liqu
Slide 16: Value accretive acquisitions: Framework for investment
3. Value accretive acquisitions Framework for investment For personal use only Primary focus for growth is the hospital channel and specialized products Deliver sustainable organic growth, efficiencies and appropriate value Strong pipeline of high value-add investments - acquiring rights to novel dr
Slide 17: BTC health company structure for growth
3. Value accretive acquisitions BTC health company structure for growth For personal use only Bio101 – 100% interest 01 Bio101 provides finance and administration solutions to companies in the Australian life sciences sector, such as accounting, company secretarial, taxation, grant applications, pay
Slide 18: Financials and outlook
1. Hospital infusion acquisition: platform for growth Financials and outlook For personal use only 2019 FY* 2020 FY • Hospital infusion business is the cornerstone Financial Performance ($’000) ($’000) investment for expansion Revenue - Revenue growth of 15% p.a. - Infusion acquisition 577 7,033 - C
Slide 19: Corporate Snapshot
Corporate Snapshot For personal use only 12-month Share Price Performance ASX ticker BTC Market capitalisation $25.75 million Share price as at 22 November 2019 $0.11 Shares on issue 245.24 million Share Options* 7.5 million Board/Management ownership 30% Net Cash at 31 October 2019 $2.8 million Top
Slide 20: Risks
Risks Key supplier risks For personal use only The supply agreement with Summit Medical Inc. accounts for >98% of the current revenues of the business. An unexpected termination of product supply, or a material change in the supply terms would have a significant impact on the business. Revenue is re
Slide 21: For personal use only
For personal use only